98-856. Agency Forms Undergoing Paperwork Reduction Act Review  

  • [Federal Register Volume 63, Number 9 (Wednesday, January 14, 1998)]
    [Notices]
    [Pages 2244-2245]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-856]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [30DAY-06-98]
    
    
    Agency Forms Undergoing Paperwork Reduction Act Review
    
        The Centers for Disease Control and Prevention (CDC) publishes a 
    list of information collection requests under review by the Office of 
    Management and Budget (OMB) in compliance with the Paperwork Reduction 
    Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
    the CDC Reports Clearance Office on (404) 639-7090. Send written 
    comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
    Executive Office Building, Room 10235; Washington, DC 20503. Written 
    comments should be received on or before February 13, 1998.
    
    Proposed Projects
    
        1. The National Home and Hospice Care Survey (NHHCS)--(0920-0298)--
    Revision--The National Home and Hospice Care Survey (NHHCS) was 
    conducted in 1992, 1993, 1994, 1996, and 1997. It is part of the Long-
    Term Care component of the National Health Care Survey. Section 306 of 
    the Public Health Service Act states that the National Center for 
    Health Statistics ``shall collect statistics on health resources * * * 
    [and] utilization of health care, including utilization of * * * 
    services of hospitals, extended care facilities, home health agencies, 
    and other institutions.'' NHHCS data are used to examine this most 
    rapidly expanding sector of the health care industry. Data from the 
    NHHCS are used widely by the health care industry and policy makers for 
    such diverse analyses as the need for various medical supplies; 
    minority access to health care; and planning for the health care needs 
    of the elderly. The NHHCS also reveals detailed information on 
    utilization patterns, as needed to make accurate assessments of the 
    need for and costs associated with such care. Data from earlier NHHCS 
    collections have been used by the Congressional Budget Office, the 
    Bureau of Health Professionals, the Maryland Health Resources Planning 
    Commission, the National Association for Home Care, and by several 
    newspapers and journals. Additional uses are expected to be similar to 
    the uses of the National Nursing Home Survey. NHHCS data cover: 
    baseline data on the characteristics of hospices and home health 
    agencies in relation to their
    
    [[Page 2245]]
    
    patients and staff, Medicare and Medicaid certification, costs to 
    patients, sources of payment, patients' functional status and 
    diagnoses. Data collection is planned for the period July-November, 
    1998. Survey design is in process now. Sample selection and preparation 
    of layout forms will precede the data collection by several months. The 
    total annual burden hours are 5,625.
    
    ----------------------------------------------------------------------------------------------------------------
                                                                                              Average               
                                                                  Number of    Number of      burden/       Total   
                            Respondents                          respondents   Responses/  response (in   burden (in
                                                                              Respondents     hours)        hours)  
    ----------------------------------------------------------------------------------------------------------------
    Agency Questionnaire.......................................         1350            1         0.333          450
    Current Patient Sampling List..............................         1350            1         0.333          450
    Current Patient Questionnaire..............................         1350            6         0.25          2025
    Discharged Patient Sampling List...........................         1350            1         0.50           675
    Discharged Patient Questionnaire...........................         1350            6         0.25          2025
    ----------------------------------------------------------------------------------------------------------------
    
        2. (NIOSH) Occupational Asthma Identification Methods -0920-0350--
    Reinstatement--Over the last decade, Occupational Asthma (OA) has 
    emerged as the most prevalent occupational respiratory disease, 
    resulting in morbidity, disability, diminished productivity, and 
    rarely, death. Prevention of OA has become one of the most important 
    goals for NIOSH. This project addresses these issues by examining the 
    potential of different asthma screening approaches as surveillance 
    tools when employed serially over time among workers at risk, and also 
    characterizes the occurrence of and risk factors for occupational 
    asthma in various high risk industries.
        The primary objective of the study is to examine the potential of 
    different asthma screening approaches as surveillance tools when 
    employed serially over time among workers at risk. A second major 
    objective is to characterize the occurrence of and risk factors for 
    occupational asthma in several industries, specifically workers rearing 
    insects for agricultural pest control, wood product workers using 
    isocyanates, and other occupational groups with different exposure 
    profiles. A series of four groups of screening measures are applied to 
    examine the potential of each measure in different situations. This 
    includes a questionnaire (including an occupational history), lung 
    function tests (shift spirometry, serial peak flow tests, airway 
    responsiveness), inflammation and immunology tests (specific and 
    nonspecific serum immunoglobulins, skin prick tests, nasal lavage for 
    cellular and biochemical factors), and environmental measurements 
    (gravimetric dusts, antigens, chemical vapors, viable organisms, 
    endotoxins). Workers exposed to 1) high molecular weight sensitizing 
    dusts, (insect particulate), 2) low molecular weight sensitizers, 
    (methylene biphenyldiisocyanate, MDI), and 3) irritant but not 
    sensitizing exposures, as well as a control group of unexposed workers, 
    are followed for two years. The results should be useful in improving 
    tools for recognition, monitoring, and surveillance of OA. In addition, 
    risk factors for OA will be further delineated, which will assist in 
    targeting OA prevention strategies for agricultural and other workers. 
    Total annual burden hours are 2,251.
    
    ----------------------------------------------------------------------------------------------------------------
                                                                                              Average               
                                                                  Number of    Number of      burden/       Total   
                             Form name                           respondents   responses/  response (in   burden (in
                                                                               respondent     hours)        hours)  
    ----------------------------------------------------------------------------------------------------------------
    Initial questionnaire......................................          250            1         0.333           83
    Follow-up questionnaire....................................          250            4         0.166          167
    Occupational questionnaire/Skin Test.......................          250            1         0.75           188
    Spirometry.................................................          250           20         0.083          417
    Peak flow tests............................................          250          300         0.016        1,250
    Blood test.................................................          250            3         0.083           63
    Nasal Lavage...............................................          250            1         0.333           83
    ----------------------------------------------------------------------------------------------------------------
    
        Dated: January 8, 1998.
    Wilma G. Johnson,
    Acting Associate Director for Policy Planning and Evaluation, Centers 
    for Disease Control and Prevention (CDC).
    [FR Doc. 98-856 Filed 1-13-98; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
01/14/1998
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
98-856
Pages:
2244-2245 (2 pages)
Docket Numbers:
30DAY-06-98
PDF File:
98-856.pdf